Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 5/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.50 |
| ▸ | HPGD | P15428 | 2/20 | 0.50 |
| ▸ | RAPGEF4 | Q8WZA2 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 5/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | USP2 | O75604 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | NOS1 | P29475 | 1/20 | 0.43 |
| ▸ | IDO1 | P14902 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL5728329 | 0.98 | HPGD (0.49) | MEN1KMT2AHPGDRAPGEF4MAPT | |
| SCHEMBL6235610 | 0.85 | MAPT (0.50) | MEN1KMT2AHPGDRAPGEF4MAPT | |
| SCHEMBL22139422 | 0.84 | HPGD (0.45) | MEN1KMT2AHPGDRAPGEF4MAPT | |
| SCHEMBL3363357 | 0.84 | MAPT (0.50) | MEN1KMT2AHPGDMAPTCYP1A2 | |
| Hydrochloric Acid SCHEMBL5857094 | 0.83 | MAPT (0.48) | MEN1KMT2AHPGDRAPGEF4MAPT | |
| SCHEMBL27642277 | 0.82 | F2R (0.48) | MEN1KMT2AHPGDRAPGEF4MAPT | |
| SCHEMBL6231348 | 0.80 | ABL1 (0.49) | MEN1KMT2AHPGDRAPGEF4MAPT | |
| Fluorobenzene SCHEMBL27677650 | 0.80 | LMNA (0.52) | MAPTCYP1A2CYP2C19ALDH1A1GAA | |
| SCHEMBL18739788 | 0.80 | ALDH1A1 (0.40) | MEN1KMT2AHPGDRAPGEF4MAPT | |
| SCHEMBL19968723 | 0.79 | ABL1 (0.51) | MEN1KMT2AHPGDMAPTCYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 286 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120049017-A | Org/ZnSO4Electrolyte, preparation method thereof and application of electrolyte in secondary battery | 同济大学 | 2025-05-27 | — | — | CN | claimed |
| CN-114420852-B | Preparation method of pure-phase RP perovskite film | 河北工业大学 | 2025-05-27 | — | — | CN | claimed |
| CN-120004697-A | Preparation method of OrgVO material and application of OrgVO material as secondary battery anode material | 同济大学 | 2025-05-16 | — | — | CN | claimed |
| CN-119726348-A | Near-infrared perovskite laser and preparation method thereof | 中国科学院半导体研究所 | 2025-03-28 | — | — | CN | claimed |
| CN-119726347-A | Non-external-cavity near-infrared perovskite laser and preparation method thereof | 中国科学院半导体研究所 | 2025-03-28 | — | — | CN | claimed |
| CN-119431706-A | Fatigue-resistant polyurethane elastomer and preparation method and application thereof | 万勋科技(深圳)有限公司 | 2025-02-14 | — | — | CN | claimed |
| CN-119371337-A | Metal halide perovskite nanocrystalline resistant to heat-induced fluorescence quenching, and preparation method and application thereof | 华南理工大学 | 2025-01-28 | — | — | CN | claimed |
| CN-118507836-B | Electrolyte for secondary lithium metal battery | 深圳欣界能源科技有限公司 | 2024-09-17 | — | — | CN | claimed |
| CN-118531514-A | Mixed-dimension perovskite/polymer composite filament, preparation method and application | 武汉纺织大学 | 2024-08-23 | — | — | CN | claimed |
| CN-118531558-A | Mixed-dimension perovskite nanofiber membrane with high fluorescence stability and preparation method thereof | 武汉纺织大学 | 2024-08-23 | — | — | CN | claimed |
| US-20160362427-A1 | BRIDGED BICYCLIC KALLIKREIN INHIBITORS | GLOBAL BLOOD THERAPEUTICS, INC. | 2016-12-15 | — | — | US | claimed |
| US-20130143824-A1 | COMPOSITIONS AND METHODS FOR ENHANCING APOPTOSIS | GENENTECH, INC. (US) | 2013-06-06 | — | — | US | claimed |
| US-20120058953-A1 | COMPOSITIONS AND METHODS FOR ENHANCING APOPTOSIS | GENENTECH, INC. (US) | 2012-03-08 | — | — | US | claimed |
| US-20110039324-A1 | COMPOSITIONS AND METHODS FOR ENHANCING APOPTOSIS | GENENTECH, INC. (US) | 2011-02-17 | — | — | US | claimed |
| US-20090148921-A1 | Compositions and methods for enhancing apoptosis | GENENTECH, INC. (US) | 2009-06-11 | — | — | US | claimed |
| EP-1590666-B1 | COMPOSITIONS AND METHODS FOR ENHANCING APOPTOSIS | GENENTECH INC (US) | 2008-07-09 | — | — | EP | claimed |
| EP-1590666-A4 | COMPOSITIONS AND METHODS FOR ENHANCING APOPTOSIS | GENENTECH INC (US) | 2006-07-26 | — | — | EP | claimed |
| EP-1590666-A1 | COMPOSITIONS AND METHODS FOR ENHANCING APOPTOSIS | Genentech, Inc. (US) | 2005-11-02 | — | — | EP | claimed |
| US-20040171554-A1 | Compositions and methods for enhancing apoptosis | GENENTECH, INC. | 2004-09-02 | — | — | US | claimed |
| WO-2004072641-A1 | COMPOSITIONS AND METHODS FOR ENHANCING APOPTOSIS | GENENTECH, INC. (US) | 2004-08-26 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160362427-A1 | BRIDGED BICYCLIC KALLIKREIN INHIBITORS | KLKB1, KLK1, KLK2 | MEN1 1461/4885KMT2A 1323/4885HPGD 385/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.